340B Advocacy Alliance Bulletin
Complete AHA Survey by May 28 on Drug Company 340B Data Policy Compliance
AHA urges Lilly to drop 340B claims-data policy, proposes neutral clearinghouse.
AHA pushes back on WSJ anti-340B editorial.
Washington Post publishes AHA letter in response to anti-340B editorial
AHA Comments on 340B Rebate Model RFI.
AHA responds to Washington Post editorial on 340B program.
AHA Seeks En Banc review of 4th Circuit 340B ruling.
Submit letters on 340b rebate model by April 20.
Urge your Representative to sign Hill Letter on 340B Rebate Model.
The AHA today urged the Health Resources and Services Administration to take immediate action to stop a new Novo Nordisk policy from taking effect by April 1.